CompletedNot Applicable

Myocardial Infarction

Turkey (Türkiye)106 participantsStarted 2023-12-01

Plain-language summary

The effect of nursing approach based on Meleis's transition theory on cardiac quality of life and adaptation to disease in patients with acute myocardial infarction. This research was planned with the idea that the approach developed based on Meleis's Transition Theory could facilitate the illness-health transition process in patients, increase their healthy behavioral gains, increase the quality of care, reduce rehospitalizations, reduce the mortality rate due to MI, and contribute to the nursing literature.

Who can participate

Age range

17 Years – 70 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: Among the patients who were hospitalized in the Cardiology Clinic of Aydın State Hospital and underwent emergency coronary angiography; * Those who were 18 years of age and older, diagnosed with MI, * Underwent coronary angiography for the first time, * Conscious, * No verbal communication barrier, * Able to read and write, * Had their polyclinic check-ups at the relevant hospital, * Agreed to participate in the study, * Had a telephone to communicate, * Living in Aydın city center and districts were included in the study. Exclusion Criteria: * Patients with COPD, * Chronic renal failure, * Cancer, arrhythmia, * Advanced aortic stenosis and pulmonary hypertension, * Systemic or pulmonary embolism, * Chronic cognitive and psychiatric diseases, * Patients scheduled for organ transplantation, * Ptage 3 and 4 heart failure (according to New York Heart Association standards), * Patients with a hospital stay longer than 10 days were excluded from the study

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Psychosocial Adjustment-Self-Report Measure (PAIS-SR ),

Timeframe: 3 months for each patient.

Health-related Quality of Life scale (HEART-QOL)

Timeframe: 3 months for each patient.

Trial details

NCT IDNCT06948123

SponsorAydin Adnan Menderes University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2024-06-15

View on ClinicalTrials.gov More Acute Coronary Syndromes trials